Difference between revisions of "Template:Article of the month"

From CannaQAWiki
Jump to navigationJump to search
(Updated article of the month text.)
(Updated article of the month text)
 
(22 intermediate revisions by the same user not shown)
Line 1: Line 1:
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig2 Hussain iScience2021 24-12.jpg|240px]]</div>
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig3 Johnson JofCannRes23 5.png|220px]]</div>
'''"[[Journal:Cannabis sativa research trends, challenges, and new-age perspectives|Cannabis sativa research trends, challenges, and new-age perspectives]]"'''
'''"[[Journal:Potency and safety analysis of hemp-derived delta-9 products: The hemp vs. cannabis demarcation problem|Potency and safety analysis of hemp-derived delta-9 products: The hemp vs. cannabis demarcation problem]]"'''


[[Cannabis sativa|''Cannabis sativa'' L.]] is one of the oldest known medicinal plants, cultivated for at least 10,000 years for several agricultural and industrial applications. However, the plant became controversial owing to some psychoactive components that have adverse effects on human health. In this review, we analyze the trends in [[cannabis]] research for the past two centuries. We discuss the historical transitions of cannabis from the category of "herbal medicine" to an [[Cannabis (drug)|illicit drug]] and back to a medicinal product [[Legality of cannabis|post-legalization]]. In addition, we address the new-age application of immuno-suppressive and anti-inflammatory cannabis extracts for the treatment of [[limswiki:COVID-19|COVID-19]] inflammation. We further address the influence of the legal aspects of [[cannabis cultivation]] for medicinal, pharmaceutical, and biotechnological research. Finally, we review the up-to-date cannabis-related genomic resources and advanced technologies for their potential application in genomic-based cannabis improvement. ('''[[Journal:Cannabis sativa research trends, challenges, and new-age perspectives|Full article...]]''')<br />
[[Hemp]]-derived [[Tetrahydrocannabinol|delta-9-tetrahydrocannabinol]] (Δ<sup>9</sup>-THC) products are freely available for sale across much of the USA, but the federal legislation allowing their sale places only minimal requirements on companies. Products must contain no more than 0.3% Δ<sup>9</sup>-THC by dry weight, but no limit is placed on overall dosage, and there is no requirement that products derived from hemp-based Δ<sup>9</sup>-THC be tested. However, some states—such as Colorado—specifically prohibit products created by “chemically modifying” a natural hemp component ... ('''[[Journal:Potency and safety analysis of hemp-derived delta-9 products: The hemp vs. cannabis demarcation problem|Full article...]]''')<br />
<br />
<br />


''Recently featured'':
''Recently featured'':
: ▪ [[Journal:Does cannabis extract obtained from cannabis flowers with maximum allowed residual level of aflatoxins and ochratoxin A have an impact on human safety and health?|Does cannabis extract obtained from cannabis flowers with maximum allowed residual level of aflatoxins and ochratoxin A have an impact on human safety and health?]]
: ▪ [[Journal:A metabolomics and big data approach to cannabis authenticity (authentomics)|A metabolomics and big data approach to cannabis authenticity (authentomics)]]
: ▪ [[Journal:Delta-8-THC: Delta-9-THC’s nicer younger sibling?|Delta-8-THC: Delta-9-THC’s nicer younger sibling?]]
: ▪ [[Journal:Cadmium bioconcentration and translocation potential in day-neutral and photoperiod-sensitive hemp grown hydroponically for the medicinal market|Cadmium bioconcentration and translocation potential in day-neutral and photoperiod-sensitive hemp grown hydroponically for the medicinal market]]
: ▪ [[Journal:Fertilization following pollination predominantly decreases phytocannabinoids accumulation and alters the accumulation of terpenoids in Cannabis inflorescences|Fertilization following pollination predominantly decreases phytocannabinoids accumulation and alters the accumulation of terpenoids in Cannabis inflorescences]]
: ▪ [[Journal:High levels of pesticides found in illicit cannabis inflorescence compared to licensed samples in Canadian study using expanded 327 pesticides multiresidue method|High levels of pesticides found in illicit cannabis inflorescence compared to licensed samples in Canadian study using expanded 327 pesticides multiresidue method]]

Latest revision as of 23:21, 30 November 2023

Fig3 Johnson JofCannRes23 5.png

"Potency and safety analysis of hemp-derived delta-9 products: The hemp vs. cannabis demarcation problem"

Hemp-derived delta-9-tetrahydrocannabinol (Δ9-THC) products are freely available for sale across much of the USA, but the federal legislation allowing their sale places only minimal requirements on companies. Products must contain no more than 0.3% Δ9-THC by dry weight, but no limit is placed on overall dosage, and there is no requirement that products derived from hemp-based Δ9-THC be tested. However, some states—such as Colorado—specifically prohibit products created by “chemically modifying” a natural hemp component ... (Full article...)

Recently featured:

▪ A metabolomics and big data approach to cannabis authenticity (authentomics)
▪ Cadmium bioconcentration and translocation potential in day-neutral and photoperiod-sensitive hemp grown hydroponically for the medicinal market
▪ High levels of pesticides found in illicit cannabis inflorescence compared to licensed samples in Canadian study using expanded 327 pesticides multiresidue method
Retrieved from "https://www.cannaqa.wiki/index.php?title=Template:Article_of_the_month&oldid=18494"